Sinil Pharmaceutical Co., Ltd. (KOSDAQ: 012790)
South Korea
· Delayed Price · Currency is KRW
7,250.00
0.00 (0.00%)
Oct 11, 2024, 9:00 AM KST
Sinil Pharmaceutical Revenue
Sinil Pharmaceutical had revenue of 24.50B KRW in the quarter ending June 30, 2024, with 35.75% growth. This brings the company's revenue in the last twelve months to 96.52B, up 18.92% year-over-year. In the year 2023, Sinil Pharmaceutical had annual revenue of 89.14B with 11.41% growth.
Revenue (ttm)
96.52B
Revenue Growth
+18.92%
P/S Ratio
0.87
Revenue / Employee
336.29M
Employees
287
Market Cap
82.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 89.14B | 9.13B | 11.41% |
Dec 31, 2022 | 80.01B | 18.25B | 29.56% |
Dec 31, 2021 | 61.75B | 316.13M | 0.51% |
Dec 31, 2020 | 61.44B | 789.70M | 1.30% |
Dec 31, 2019 | 60.65B | 7.37B | 13.84% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition